Miura Partners has acquired HTBA, a global leader in natural ingredients such as flavonoids and active forms of vitamin B12, as part of its strategy to enhance growth in the health and nutrition sectors.

Information on the Target

HTBA (HealthTech Bioactives) is a global leader in the production and commercialization of natural ingredients, including citrus flavonoids and active forms of vitamin B12. Established in Barcelona over 40 years ago, HTBA has pioneered innovative processes for creating high-quality, natural ingredients that benefit both human and animal health, maintaining a strong focus on sustainability and environmental protection throughout its supply chain.

The company operates a technologically advanced production facility in Beniel, Murcia, and has an operational subsidiary in Cincinnati, USA. Currently, HTBA serves clients in more than 60 countries, solidifying its position as a trusted provider in the health and nutrition sectors.

Industry Overview in the Target’s Specific Country

The natural ingredients market has experienced significant growth in recent years, driven by rising consumer awareness of health and wellness. In Spain, the emphasis on sustainable and natural products has spurred innovation and i